Correlation of Coagulation Dysfunction with Infection and Hypercapnia in Acute Exacerbation of COPD Patients
Li-Li Zheng,Sheng Wang,Ze-Geng Li,Lei Han,Chun-Dong Zhu,Chun-Ying Li,Xing-Xing Zhang,Xue Deng
DOI: https://doi.org/10.2147/IDR.S421925
2023-08-19
Infection and Drug Resistance
Abstract:Li-Li Zheng, 1 Sheng Wang, 1 Ze-Geng Li, 2 Lei Han, 2 Chun-Dong Zhu, 1 Chun-Ying Li, 1 Xing-Xing Zhang, 1 Xue Deng 1 1 Department of Respiratory Medicine of Geriatrics Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, 230000, People's Republic of China; 2 Anhui University of Traditional Chinese Medicine, Hefei, 230000, People's Republic of China Correspondence: Sheng Wang, Department of Respiratory Medicine, Geriatrics Center, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, 117 Meishan Road, Shushan District, Hefei, 230000, People's Republic of China, Tel +86 13855182043, Email Background: This study aims to explore the factors influencing the coagulation function of patients with chronic obstructive pulmonary disease (COPD) and its effects on thrombosis. Methods: A total of 155 COPD patients, including 118 patients with acute exacerbation of COPD (AECOPD) and 37 patients with stable COPD (SCOPD), were enrolled in this study. Meanwhile, 50 patients with gastrointestinal polyps found during physical examination and treated with surgery in the same period were enrolled as the control group. The basic data, routine blood tests, C-reactive protein (CRP), procalcitonin (PCT), and coagulation indexes of the three groups were collected, as well as arterial blood gas indexes of AECOPD patients. Results: The differences in erythrocyte count and hemoglobin among groups were not statistically significant. Compared with the SCOPD group and control group, white blood cell (WBC), neutrophil percentage, PCT, CRP, prothrombin time (PT), and fibrinogen (FIB) in the AECOPD group increased significantly, while the international normalized ratio (INR) decreased (P 0.05). Thrombin time (TT) in the AECOPD group was shorter than that of the control group, and PT was longer than that of the SCOPD group (P < 0.05). Five patients with AECOPD and one patient with SCOPD had venous thrombosis. Conclusion: The abnormal coagulation function in AECOPD patients is related to the degree of infection and hypercapnia, which may be a risk factor for thrombosis. Keywords: acute exacerbation of chronic obstructive pulmonary disease, AECOPD, abnormal coagulation function, infection, thrombosis Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable chronic airway disease that is characterized by persistent airflow restriction and corresponding respiratory symptoms; its pathological changes are mainly airway and/or alveolar abnormalities, which are usually related to significant exposure to harmful particles or gases, genetic susceptibility, abnormal inflammatory response, abnormal lung development, and other host factors participating in pathogenesis. 1,2 Academician Chen Wang et al 3 reveal that, at present, the overall prevalence of COPD among people aged 20 and over in China is 8.6%, of which the prevalence among people aged 40 and over is 13.7%; it is estimated that nearly 100 million people in China have COPD. COPD patients suffer 0.5–3.5 times more each year from acute exacerbation, and the average hospitalization cost per person is up to 12,000 yuan, which has seriously increased the economic burden of patients and society. The early inflammatory response of COPD is confined to the trachea and lungs, but in the course of the disease, hypoxia and chronic inflammation affect the whole body. When respiratory failure occurs in patients with acute exacerbation of COPD (AECOPD), circulatory and coagulation dysfunction often occurs, which is considered to be the cause of thrombotic events. 4 Furthermore, abnormal coagulation and thrombosis may accelerate the progress of COPD, resulting in prolonged hospitalization, high hospitalization costs, poor prognosis, and even increased mortality. Coagulation dysfunction and its role in COPD have been explored for many years. More and more evidence show that a hypercoagulable state exists in COPD, involving changes in a variety of coagulation factors. 5 However, the pathogenesis of coagulation dysfunction caused by COPD remains unclear. Its main pathological manifestation, though, is local hypoxia in the lung, induced by inflammatory mediators acting on vasoactive receptors in the lung parenchyma, thereby resulting in repeated damage and repair of the airway wall, thickening and narrowing of the lumen, destruction of lung parenchyma, and thickening of the pulmonary vascular wall. 6,7 Inflammatory mediators aggravate th -Abstract Truncated-
pharmacology & pharmacy,infectious diseases